Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

Several studies have demonstrated an expression of the prostate-specific membrane antigen (PSMA) in the cancer-related neovasculature of thyroid malignancies. Due to the poor prognosis and limited therapeutic options for patients with anaplastic (ATC) and poorly differentiated (PDTC) thyroid carcino...

Full description

Bibliographic Details
Main Authors: Sabine Wächter, Pietro Di Fazio, Elisabeth Maurer, Jerena Manoharan, Corinna Keber, Andreas Pfestroff, Damiano Librizzi, Detlef K. Bartsch, Markus Luster, Friederike Eilsberger
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
anaplastic thyroid carcinoma
poorly differentiated thyroid carcinoma
prostate-specific membrane antigen
theranostic
neovasculature
immunohistochemistry
Online Access:https://www.mdpi.com/2072-6694/13/22/5688

Internet

https://www.mdpi.com/2072-6694/13/22/5688

Similar Items